Device User Fee Program Future May Hinge On Lobbying Approps Staff
This article was originally published in The Gray Sheet
Executive Summary
Improved relations with Capitol Hill staffers responsible for FDA appropriations will be key to industry's efforts to sustain the medical device user fee program and ensure that premarket review performance goals are met